In addition, CpdA dramatically attenuated TLR4-induced IL-6, IL-8 and XIAP expressions in both MDA-MB-231 BCA (Fig. 4A) and MDA-MB-435 melanoma cells (Fig. 4B) compared to cells with only PTX treatment. Here, TLR4 is linked to melanoma.